Sponsor Pipeline

GlaxoSmithKline (GSK) Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
156
Active Trials
72
Recruiting
54
Phase 3
10
Disease Areas
42
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-13 NCT07201051
A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With…
Enrollment reduced: 446 -> 363 participants
2026-08-13 NCT07201051
A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With…
Trial sites expanded: 46 -> 134 locations
2026-08-12 NCT07085702
A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of the GSK 4-component…
date change Primary completion pushed: 2026-11-30 -> 2027-06-29
2026-08-12 NCT07085702
A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of the GSK 4-component…
date change Completion pushed: 2026-11-30 -> 2027-06-29
2026-08-06 NCT07701993
A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared…
Recruitment opened
2026-08-06 NCT07704892
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult…
Recruitment opened
2026-08-04 NCT07220109
A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus…
Enrollment closed, study ongoing
2026-08-04 NCT07220109
A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus…
date change Primary completion moved earlier: 2026-09-25 -> 2026-07-20
2026-08-04 NCT07220109
A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus…
date change Completion moved earlier: 2027-03-12 -> 2026-12-31
2026-08-04 NCT06885034
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other…
Trial arms changed: 5 -> 9
2026-08-04 NCT06613698
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in…
Trial sites expanded: 131 -> 140 locations
2026-08-04 NCT06613698
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in…
date change Primary completion pushed: 2027-08-02 -> 2027-11-26
2026-08-04 NCT03843359
A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With…
critical Trial terminated
2026-08-04 NCT03843359
A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With…
critical Trial terminated: Business Decision
2026-08-04 NCT03843359
A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With…
date change Completion moved earlier: 2026-03-31 -> 2026-01-09
2026-07-31 NCT07406334
A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal…
Recruitment opened
2026-07-31 NCT07092865
A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory…
Enrollment closed, study ongoing
2026-07-31 NCT06573281
A Study on the Safety and Immune Response to an mRNA-based RSV Investigational Vaccine in…
Trial completed
2026-07-31 NCT06573281
A Study on the Safety and Immune Response to an mRNA-based RSV Investigational Vaccine in…
date change Primary completion moved earlier: 2026-04-13 -> 2026-02-26
2026-07-31 NCT06573281
A Study on the Safety and Immune Response to an mRNA-based RSV Investigational Vaccine in…
date change Completion moved earlier: 2026-04-13 -> 2026-02-26
Showing 20 of 42 changes detected in the last 30 days.
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-08-05 NCT07747467 A Study to Investigate the Safety and Tolerability of Multiple Study Interventions in… Phase 1 Not Yet Recruiting
2026-08-05 NCT07747480 A Sub Study to Investigate the Safety and Tolerability of Aletekitug in Participants With… Phase 1 Not Yet Recruiting
2026-08-03 NCT07740720 A Study of the Duration of Dostarlimab in Untreated Mismatch Repair Deficient (dMMR)/… Phase 3 Not Yet Recruiting
2026-08-03 NCT07742527 A Study to Evaluate the Subcutaneous Belantamab (BCMAb) Formulation Versus Intravenous… Phase 1 Not Yet Recruiting
2026-08-03 NCT07742644 A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps… Phase 3 Not Yet Recruiting
Active Trials by Phase
Phase 4
9
Phase 3
51
Phase 2/3
3
Phase 2
36
Phase 1/2
22
Phase 1
33
Not specified
2
Active Trials — top 25 of 156
NCT IDTitleConditionStatus
Phase 4
NCT07502560 A Study to Evaluate the Effect of Recombinant Zoster Vaccine on New Diagnosis of Dementia… Herpes Zoster Recruiting
NCT06411249 A Study Describing the Efficacy and Safety of Belimumab Administered in Adult… Systemic Lupus Erythematosus Recruiting
NCT06887933 A Trial to Evaluate the Safety of Niraparib Tablets in Adult Female Participants With… Ovarian Neoplasms Not Yet Recruiting
NCT06897527 A Study to Evaluate the Safety of Dostarlimab in Adult Participants in India With… Neoplasms, Endometrial Not Yet Recruiting
NCT06041386 REIMAGINE - Real World EvaluatIon of Mepolizumab in Severe Asthma achievinG on Treatment… Asthma Active, Not Recruiting
NCT06372496 Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care… Asthma Active, Not Recruiting
NCT06113198 A Study on the Immune Response and Safety of a Vaccine Against N. Meningitidis Serogroup… Meningitis, Meningococcal Active, Not Recruiting
NCT07652515 A Study to Evaluate the Safety of Dostarlimab in Adult Participants in India With Primary… Neoplasms, Endometrial Not Yet Recruiting
NCT07701967 Efficacy and Safety of Depemokimab Monotherapy Without Concomitant Use of Intranasal… Nasal Polyps Not Yet Recruiting
Phase 3
NCT06666491 An Interventional Study to Compare the Efficacy and Safety of Tafenoquine (TQ) and… Malaria, Vivax Recruiting
NCT06959095 Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive… Pulmonary Disease, Chronic Obstructive Recruiting
NCT06716606 A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With… Connective Tissue Diseases Recruiting
NCT05855200 Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III… Colonic Neoplasms Recruiting
NCT06572384 A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease… Lung Diseases, Interstitial Recruiting
NCT06961214 Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive… Pulmonary Disease, Chronic Obstructive Recruiting
NCT06679101 A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and… Multiple Myeloma Recruiting
NCT06256588 A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally… Neoplasms, Head and Neck Recruiting
NCT06693895 A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy… Chickenpox Recruiting
NCT06740630 A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When… Chickenpox Recruiting
NCT06806137 A Study on the Immune Response and Safety of the Second Dose of an Investigational… Chickenpox Recruiting
NCT06855160 A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a… Chickenpox Recruiting
NCT07218926 A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With… Gastrointestinal Neoplasms Recruiting
NCT07650084 A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic… Refractory Chronic Cough Recruiting
NCT07456033 A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and… Asthma Recruiting
NCT06979323 Depemokimab Asthma Imaging and Bronchoscopy Sub-Study Asthma Recruiting
See all 156 active GlaxoSmithKline (GSK) trials with filters →
Disease Areas
Get alerts when GlaxoSmithKline (GSK)'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free